Why is Beta Drugs Ltd falling/rising?

As of 23-Jul, Beta Drugs Ltd is experiencing a price increase, with the current price at 1,702.95, reflecting a rise of 32.95 or 1.97%. The stock has outperformed its sector by 1.46% today, although it is currently trading higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has seen a significant decline in investor participation, with delivery volume dropping by 46.19% compared to the 5-day average. Year-to-date, the stock is down 10.77%, but it has shown strong performance over the longer term, with a 34.84% increase over the past year and an impressive 1826.47% rise over the past five years. There are no specific positive or negative factors available to further explain the stock's recent movement.
In the broader market context, Beta Drugs Ltd's short-term return of +1.55% over the past week significantly outpaces the Sensex, which has only increased by 0.03% during the same period. However, the stock's performance over the past month shows a decline of 4.07%, contrasting with the Sensex's gain of 0.99%. This indicates that while the stock is currently rising, it has faced challenges in the recent past compared to the benchmark, suggesting a mixed outlook in the context of broader market trends.